Researchers has significantly boosted its progress of a novel solution for ATTR-CM, leveraging the compound. Initial clinical information reveals promising benefits for those affected by this severe illness. The https://bridgebio354983.azzablog.com/42578355/bridgebio-advances-amyloidosis-treatment-with-the-therapy